Abstract
Reversible posterior leukoencephalopathy syndrome (RPLS) was described by Hinchey and colleagues in 1996. The disorder occurs predominantly in patients with acute hypertension and/or on pharmacological immunosuppression. We report a 6-year-old male with cerebral X-linked adrenoleukodystrophy who received an HLA-matched unrelated bone marrow transplant (BMT). Cyclosporine was used as graft-versus-host disease prophylaxis. At 55 days post-BMT, his cyclosporine concentrations were high for several days and the concentration was still high on day 70 (353 µg/L). He presented 83 days post-BMT with new onset of headache, lethargy, acute visual loss and focal seizures. He was not hypertensive. MRI of the head revealed signal changes that now extended more peripherally into the subcortical and cortical regions of the occipital and temporal lobes. The patient's cyclosporine was stopped for 5 days. The patient's vision returned to normal and his headaches and lethargy resolved with no further seizures 3 weeks later. Follow-up MRI of the head 2 months later showed almost complete resolution of the cortical signal abnormalities. It is important to consider RPLS in patients with cerebral adrenoleukodystrophy who present with acute neurological deterioration. Attention to the pattern of white matter and the presence of cortical grey matter involvement on neuroimaging is important for the diagnosis. When appropriate management is initiated, that is controlling hypertension when present and discontinuing or reducing the dose of offending immunosuppressive agents, the acute neurological symptoms will usually resolve.
Similar content being viewed by others
REFERENCES
Antunes NL, Small TN, George D, Boulad F, Lis E (1999) Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 20: 241–243.
Garg RK (2001) Posterior leukoencephalopathy syndrome. Postgrad Med J 77: 24–28.
Gijtenbeek JM, van den Bent MJ, Vecht Ch J (1999) Cyclosporine neurotoxicity: a review. J Neurol 246: 339–346.
Hinchey J, Chaves C, Appignani B, et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334: 494–500.
Jarosz JM, Howlett DC, Cox TCS, Bingham JB (1997) Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology 39: 711–715.
Kondo A, Suzuki K (1993) The blood brain barrier in human leukodystrophies and allied disease. Ultrastructural and morphometric studies on the capillaries in brain biopsies. Clin Neuropathol 12(3): 169–174.
Moser HW, Smith KD, Watkins PA, Powers J, Moser AB (2001) X-linked adrenoleukodystrophy. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3257–3302.
Roberts JM, Redman CWG (1993) Pre-eclampsia: more than pregnancy-induced hyper-tension. Lancet 341: 1447–1451. [Erratum, Lancet 1993; 342: 504.]
Yamamoto T (1999) Reversible posterior leukoencephalopathy syndrome. Is it reversible and thus benign? Intern Med 38(1): 4–5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chan, A.K.J., Bhargava, R., Desai, S. et al. Reversible posterior leukoencephalopathy syndrome in a child with cerebral X-linked adrenoleukodystrophy treated with cyclosporine after bone marrow transplantation. J Inherit Metab Dis 26, 527–536 (2003). https://doi.org/10.1023/A:1025943829843
Issue Date:
DOI: https://doi.org/10.1023/A:1025943829843